Gossamer Partners With Chiesi To Accelerate Seralutinib Development

Cash Will Fund Trial In Second, Larger Indication

 
• By Mandy Jackson
Pulmonary hypertension is a cardiovascular condition characterized by high blood pressure in the pulmonary arteries 3D rendering
Topline Phase III data in PAH are expected in Q4 2025 • Source: Shutterstock

More from Deals

More from Business